Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

CEFTAROLINE FOSAMIL vs CEFTAZIDIME: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

CEFTAROLINE FOSAMIL vs CEFTAZIDIME: Safety Overview

Metric CEFTAROLINE FOSAMIL CEFTAZIDIME
Total FAERS Reports 789 3,158
Deaths Reported 177 696
Death Rate 22.4% 22.0%
Hospitalizations 258 1,503
Average Patient Age 56.6 yrs 52.0 yrs
% Female Patients 37.8% 43.3%
FDA Approval Date Oct 29, 2010 Apr 28, 1989
Manufacturer Allergan, Inc. Hospira, Inc.
Route INTRAVENOUS INTRAVENOUS
Marketing Status Prescription Discontinued